Insights into Company

Cipla ↗

Part of Cipla.

1935 📍 Mumbai, Maharashtra, India Active NSE CIPLA CIN L24239MH1935PLC002380 Pharmaceuticals & Healthcare
Search companies

Key Metrics of Cipla

Revenue₹18,980 Cr▼ 0.3% YoYFY 2025-26
EBITDA₹5,314 Cr▼ 24.7% YoY
Net profit₹3,515 Cr▼ 31.8% YoY
Net worth₹34,201 Cr▲ 6.5% YoY
Competitors10identified

About Cipla

Part of Cipla.

Sectors

Pharmaceuticals & HealthcareFormulations & Contract ManufacturingLarge Pharma CompaniesState-wise Pharma ManufacturersGeneric Formulations

Company details

Website
cipla.com
Founded
1935
Registered office
Cipla House Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, Mumbai, In-mh, 400013
Listed
NSE: CIPLA · ₹1,338.00

Operational Areas of Cipla

Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Pharmaceuticals & Healthcare›Large Pharma Companies
Pharmaceuticals & Healthcare›State-wise Pharma Manufacturers
Pharmaceuticals & Healthcare›Generic Formulations

Company summary

Entity details

CINL24239MH1935PLC002380
LEI code335800KMJJYEDDK82Q34
State codeMH
PIN code400013
Current legal nameCIPLA
Classification—
Listing statusListed (NSE: CIPLA)
Registration no.002380
Company age91 years, 9 months
PAN—
CountryIndia
CityMumbai
StateMaharashtra
Current statusActive
Date of incorporation01 Jan 1935
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026

Industry classification

NIC code24239
Description of main activityManufacture of chemicals and chemical products (incl. pharmaceuticals)
Description of business activityManufacture of chemicals and chemical products (incl. pharmaceuticals)
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date · 6 days left
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 36 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit assessment · Manufacturing

Rating Methodology – Manufacturing Companies (Mar 2025) · Standalone accounts · FY 2025-26

Indicative long-term—
Indicative short-term—
Score—
LiquidityStrong
DirectionStable

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
Information on file56% · missing: Capex / investment plans, Lender details, Auditor details, Recent rating review (last 15 months)

Indicative assessment from public data using the published methodology factors; not a credit rating.

Registered office and contact

Registered officeCIPLA HOUSE PENINSULA BUSINESS PARK GANPATRAO KADAM MARG LOWER PAREL, MUMBAI, IN-MH, 400013
GSTIN—
Email—
Websitehttp://www.cipla.com
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Cipla

Competitors10identified
Locations3most in India

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Dr. Reddy's Laboratories Part of Dr. Reddy's Laboratories. drreddys.com 1984 India
Aurobindo Pharma Part of Aurobindo Pharma. aurobindo.com 1986 Hyderabad, India
Lupin Ltd. Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare lupin.com 1968 India
Glenmark Pharmaceuticals Part of Glenmark Pharmaceuticals. glenmarkpharma.com 1977 Mumbai, India
Biocon Part of Biocon. biocon.com 1978 Bangalore, India
ALKEM LABORATORIES LIMITED Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare alkemlabs.com 1973 Mumbai, Maharashtra, India
Torrent Pharmaceuticals Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare torrentpharma.com 1959 Ahmedabad, India
ASTER DM QUALITY CARE LIMITED Discovered Companies · Other Industries — — Hyderabad, Telangana, India
Thomas Cook India Part of Thomas Cook Group. thomascook.in 1978 Mumbai, India
Divi's Laboratories Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare divislabs.com 1990 Hyderabad, India

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Group companies

Part of Cipla

Business activities and related parties

pharmaceutical industry

Filings

No filings on record yet.